Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A multimodal pain management combination that targets different pain pathways. Gabapentin reduces abnormal electrical activity in the brain and alters pain signal processing, primarily treating nerve pain. Ibuprofen, an NSAID, reduces inflammation by inhibiting prostaglandin production. Acetaminophen provides general pain relief through central mechanisms. Bupivacaine delivers local anesthesia. This combination approach may provide enhanced pain control through complementary mechanisms, particularly useful in perioperative and post-injury pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + acetaminophen + gabapentin + bupivacaine.